165 related articles for article (PubMed ID: 25697482)
1. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ.
Wang H; Bao W; Jiang F; Che Q; Chen Z; Wang F; Tong H; Dai C; He X; Liao Y; Liu B; Sun J; Wan X
Cancer Lett; 2015 May; 360(2):269-79. PubMed ID: 25697482
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells.
Ali A; Wang Z; Fu J; Ji L; Liu J; Li L; Wang H; Chen J; Caulin C; Myers JN; Zhang P; Xiao J; Zhang B; Li X
Nat Commun; 2013; 4():2667. PubMed ID: 24157709
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP
Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974
[TBL] [Abstract][Full Text] [Related]
4. Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation.
Wu AY; Gu LY; Cang W; Cheng MX; Wang WJ; Di W; Huang L; Qiu LH
J Exp Clin Cancer Res; 2019 Apr; 38(1):176. PubMed ID: 31023317
[TBL] [Abstract][Full Text] [Related]
5. Expression of proteasome activator REGγ in human laryngeal carcinoma and associations with tumor suppressor proteins.
Li LP; Cheng WB; Li H; Li W; Yang H; Wen DH; Tang YD
Asian Pac J Cancer Prev; 2012; 13(6):2699-703. PubMed ID: 22938444
[TBL] [Abstract][Full Text] [Related]
6. miR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGγ.
Shi Y; Luo X; Li P; Tan J; Wang X; Xiang T; Ren G
Cancer Lett; 2015 Mar; 358(1):27-36. PubMed ID: 25511742
[TBL] [Abstract][Full Text] [Related]
7. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
8. REGγ potentiates TGF-β/Smad signal dependent epithelial-mesenchymal transition in thyroid cancer cells.
Bhatti MZ; Pan L; Wang T; Shi P; Li L
Cell Signal; 2019 Dec; 64():109412. PubMed ID: 31491459
[TBL] [Abstract][Full Text] [Related]
9. REGγ deficiency promotes premature aging via the casein kinase 1 pathway.
Li L; Zhao D; Wei H; Yao L; Dang Y; Amjad A; Xu J; Liu J; Guo L; Li D; Li Z; Zuo D; Zhang Y; Liu J; Huang S; Jia C; Wang L; Wang Y; Xie Y; Luo J; Zhang B; Luo H; Donehower LA; Moses RE; Xiao J; O'Malley BW; Li X
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11005-10. PubMed ID: 23766372
[TBL] [Abstract][Full Text] [Related]
10. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma.
Chen S; Wang Q; Wang L; Chen H; Gao X; Gong D; Ma J; Kubra S; Yao X; Li X; Li L; Zhai W; Zheng J
Cell Death Dis; 2018 May; 9(6):627. PubMed ID: 29795381
[TBL] [Abstract][Full Text] [Related]
11. Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor.
Lai ZY; Tsai KY; Chang SJ; Chuang YJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445495
[TBL] [Abstract][Full Text] [Related]
12. REGgamma modulates p53 activity by regulating its cellular localization.
Liu J; Yu G; Zhao Y; Zhao D; Wang Y; Wang L; Liu J; Li L; Zeng Y; Dang Y; Wang C; Gao G; Long W; Lonard DM; Qiao S; Tsai MJ; Zhang B; Luo H; Li X
J Cell Sci; 2010 Dec; 123(Pt 23):4076-84. PubMed ID: 21084564
[TBL] [Abstract][Full Text] [Related]
13. Proteasomes reactivator REG gamma enchances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis.
Tian M; Xiaoyi W; Xiaotao L; Guosheng R
Cell Mol Biol (Noisy-le-grand); 2009 Jun; 55 Suppl():OL1121-31. PubMed ID: 19656465
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells.
Nakazawa S; Sakata KI; Liang S; Yoshikawa K; Iizasa H; Tada M; Hamada JI; Kashiwazaki H; Kitagawa Y; Yamazaki Y
Biomed Res; 2019; 40(1):37-49. PubMed ID: 30787262
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.
Neilsen PM; Noll JE; Mattiske S; Bracken CP; Gregory PA; Schulz RB; Lim SP; Kumar R; Suetani RJ; Goodall GJ; Callen DF
Oncogene; 2013 Jun; 32(24):2992-3000. PubMed ID: 22797073
[TBL] [Abstract][Full Text] [Related]
16. The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.
Gao X; Wang Q; Wang Y; Liu J; Liu S; Liu J; Zhou X; Zhou L; Chen H; Pan L; Chen J; Wang D; Zhang Q; Shen S; Xiao Y; Wu Z; Cheng Y; Chen G; Kubra S; Qin J; Huang L; Zhang P; Wang C; Moses RE; Lonard DM; Malley BWO; Fares F; Zhang B; Li X; Li L; Xiao J
Nat Commun; 2020 Aug; 11(1):3904. PubMed ID: 32764536
[TBL] [Abstract][Full Text] [Related]
17. The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression.
De Souza C; Madden JA; Minn D; Kumar VE; Montoya DJ; Nambiar R; Zhu Z; Xiao WW; Tahmassebi N; Kathi H; Nelson N; Karnezis AN; Chien J
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126568
[TBL] [Abstract][Full Text] [Related]
18. The REGγ-Proteasome Regulates Spermatogenesis Partially by P53-PLZF Signaling.
Gao X; Chen H; Liu J; Shen S; Wang Q; Clement TM; Deskin BJ; Chen C; Zhao D; Wang L; Guo L; Ma X; Zhang B; Xu Y; Li X; Li L
Stem Cell Reports; 2019 Sep; 13(3):559-571. PubMed ID: 31402338
[TBL] [Abstract][Full Text] [Related]
19. Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation.
Gao G; Wong J; Zhang J; Mao I; Shravah J; Wu Y; Xiao A; Li X; Luo H
J Virol; 2010 Nov; 84(21):11056-66. PubMed ID: 20719955
[TBL] [Abstract][Full Text] [Related]
20. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer.
Bao W; Fan Q; Luo X; Cheng WW; Wang YD; Li ZN; Chen XL; Wu D
Oncol Rep; 2013 Aug; 30(2):723-30. PubMed ID: 23708264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
